Heart Doc VIP with Dr. Joel Kahn
Heart Doc VIP with Dr. Joel Kahn
Symphony Natural Health: Dr. Kahn's Exploration of Herbatonin and Maca's Healing Power
Loading
/

Symphony Natural Health: Dr. Kahn’s Exploration of Herbatonin and Maca’s Healing Power

Dr. Kahn is dedicated to meticulous research on natural products, often testing them on himself before recommending them. After touching upon a few mini-topics in this episode, he unveils his new role as a brand ambassador for SNH, a company he has trusted and used for years. Discover more about SNH at https://symphonynaturalhealth.com/.

Delving deeper, Dr. Kahn elucidates the benefits of "phytomelatonin" Herbatonin compared to the synthetic alternatives that dominate 99% of the market. Notably, Herbatonin boasts a superior anti-inflammatory and antioxidant profile. Later, he delves into the therapeutic potential of maca for various hormonal disorders and highlights the SNH product line, sharing his extensive experience with these products.

For listeners interested in trying SNH products, Dr. Kahn provides a special discount code: Kahn10, available on the SNH website.

More From Current Show

This week, Dr. Kahn presents the case of a patient seen this month at the Kahn Center for...
Listen Now
This week, Dr. Kahn presents a new scientific statement by the American College of Cardiology on nutrition to...
Listen Now
This week, as a bonus, Dr. Kahn interviews a Detroit clothing legend, Phil, who celebrated his 100th birthday...
Listen Now
This week, Dr. Kahn brings back the topic of Mankai Duckweed, the smallest edible plant, which provides a...
Listen Now
In this episode, Dr. Kahn interviews Ben Tammetta, founder of H2Biohacker, about inhaled molecular hydrogen. They discuss the...
Listen Now
This week, Dr. Kahn discusses a large study on the impact of whole-grain consumption on heart health. The...
Listen Now
This week, Dr. Kahn discusses two large new studies examining the role of routine coronary artery calcium CT...
Listen Now
This week, Dr. Kahn discusses the widespread disappointment following Novartis' announcement that its 8,000-patient HORIZON trial of a...
Listen Now

Related Episodes

No related episodes found.